BioCentury | Dec 21, 2020
Finance

Dec. 21-23 Financial Quick Takes: Venture rounds for SomaLogic, ONL; plus Jacobio’s HK listing, Cullinan, Gracell and Zhaoke file for IPOs, and more

SomaLogic tops off recent series AProteomics company SomaLogic Inc. added another $81 million to the crossover-heavy series A financing it disclosed in November, bringing the round’s total to $214 million. New investors in the second close...
BioCentury | Jun 9, 2017
Financial News

ONL Therapeutics raises $4.3M in series A

On May 17, ophthalmic company ONL Therapeutics Inc. (Ann Arbor, Mich.) raised $4.3 million in a series A round, including the conversion of a $1 million bridge loan. Investors included Novartis AG (NYSE:NVS; SIX:NOVN), University...
BioCentury | Dec 24, 2007
Emerging Company Profile

Corporate Profile

...University Corporate partners: None Number of employees: 9 Funds raised: $13 million Investors: Grand Angels, Biosciences Research Commercialization...
Items per page:
1 - 3 of 3
BioCentury | Dec 21, 2020
Finance

Dec. 21-23 Financial Quick Takes: Venture rounds for SomaLogic, ONL; plus Jacobio’s HK listing, Cullinan, Gracell and Zhaoke file for IPOs, and more

SomaLogic tops off recent series AProteomics company SomaLogic Inc. added another $81 million to the crossover-heavy series A financing it disclosed in November, bringing the round’s total to $214 million. New investors in the second close...
BioCentury | Jun 9, 2017
Financial News

ONL Therapeutics raises $4.3M in series A

On May 17, ophthalmic company ONL Therapeutics Inc. (Ann Arbor, Mich.) raised $4.3 million in a series A round, including the conversion of a $1 million bridge loan. Investors included Novartis AG (NYSE:NVS; SIX:NOVN), University...
BioCentury | Dec 24, 2007
Emerging Company Profile

Corporate Profile

...University Corporate partners: None Number of employees: 9 Funds raised: $13 million Investors: Grand Angels, Biosciences Research Commercialization...
Items per page:
1 - 3 of 3